In Brief: Chantal
This article was originally published in The Rose Sheet
Executive Summary
Chantal: Appoints Gary Burnison to CFO, effective July 8, Chantal Pharmaceutical announced June 25. He will take over financial responsibilities previously handled by President and CEO Chantal Burnison, which include focusing on company strategy and readying the firm "for both domestic and international growth," the firm said. Gary Burnison's appointment follows recent reports in the lay press that Chantal overstated its revenues for fiscal 1995 and the first quarter 1996. In addition, Chantal was notified by NASDAQ in May that it risked delisting from the NASDAQ SmallCap stock market due to overdue reporting of its second and third quarter financial results ("The Rose Sheet" May 27, p. 8). Burnison comes to Chantal with 12 years of public accounting and financial management experience. He most recently held the position of senior VP at the international investment banking firm Jefferies & Company. Chantal Burnison and Gary Burnison are not related, according to the company...